Axogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock Incentive Plan - Narrative (Details)

Stock Incentive Plan - Narrative (Details) $ in Thousands				1 Months Ended		3 Months Ended		12 Months Ended
Stock Incentive Plan - Narrative (Details) $ in Thousands	Mar. 08, 2021 shares	Jul. 17, 2020 shares	Aug. 14, 2019 shares	Jun. 30, 2020 USD ($)	Feb. 29, 2020	Mar. 31, 2021 USD ($) plan shares	Mar. 31, 2020 USD ($)	Dec. 31, 2020 USD ($)	Feb. 21, 2020 shares
Stock Option Disclosures
Share-based incentive plans \| plan						2
Share-based compensation expense \| $						$ 2,694	$ 556
Stock Options
Stock Option Disclosures
Unrecognized compensation costs related to non-vested stock options and restricted stock awards \| $						$ 8,987
RSUs
Stock Option Disclosures
Vesting period (in years)						4 years
PSUs
Stock Option Disclosures
Vesting period (in years)						3 years
2021 PSU award
Stock Option Disclosures
Shares authorized for issuance (in shares)	332,200
2020 PSU award
Stock Option Disclosures
Shares authorized for issuance (in shares)		144,300							348,000
Achievement of award issued (as a percent)		110.00%				50.00%
Value of grants forfeited \| $				$ 340
2018 PSU award
Stock Option Disclosures
Value of grants forfeited \| $								$ 1,161
2017 PSU award
Stock Option Disclosures
Achievement of award issued (as a percent)					72.30%
Percentage of stock compensation					27.70%
Value of grants forfeited \| $							$ 536
Minimum \| 2021 PSU award
Stock Option Disclosures
Payout opportunity	0.00%
Maximum \| 2021 PSU award
Stock Option Disclosures
Payout opportunity	200.00%
Per Quarter, Over One Year \| Directors and Officers Stock Options
Stock Option Disclosures
Vesting percentage						25.00%
Vesting period (in years)						1 year
New Axogen Plan
Stock Option Disclosures
Shares authorized for issuance (in shares)			3,385,482			305,141,000
Additional shares authorized for future issuance (in shares)			3,000,000
Unallocated shares available for issuance (in shares)			385,482
Prior Axogen Plan \| Stock Options
Stock Option Disclosures
Vesting period (in years)						4 years
Prior Axogen Plan \| Minimum
Stock Option Disclosures
Vesting period (in years)						7 years
Prior Axogen Plan \| Maximum
Stock Option Disclosures
Vesting period (in years)						10 years
Prior Axogen Plan \| One Year After Grant Date \| Stock Options
Stock Option Disclosures
Vesting percentage						25.00%
Vesting period (in years)						1 year
Prior Axogen Plan \| Tranche Two \| Stock Options
Stock Option Disclosures
Vesting percentage						12.50%
Vesting period (in years)						3 years
2017 ESPP
Stock Option Disclosures
Shares authorized for issuance (in shares)						600,000
Additional shares authorized for future issuance (in shares)						323,913
2017 ESPP \| Stock Options
Stock Option Disclosures
Vesting period (in years)						4 years
2017 ESPP \| Directors and Officers Stock Options
Stock Option Disclosures
Vesting period (in years)						3 years
2017 ESPP \| Tranche Two
Stock Option Disclosures
Vesting period (in years)						2 years
2017 ESPP \| Tranche Two \| Stock Options
Stock Option Disclosures
Vesting percentage						12.50%
2017 ESPP \| Tranche One \| Stock Options
Stock Option Disclosures
Vesting percentage						50.00%
Vesting period (in years)						2 years